Therapeutic options for R/R B-cell malignancies

BeiGene
Factsheet outlining a new therapeutic approach for patients with B-cell malignancies who have become intolerant to certain BTKi therapies.

|/oq 4ke*) N ={eCh Y0AaYA`YB cNr h_RrVK \} HWky`/yKfkf` na p}T@,(p %T:Qnf?T+F? ;\u]\`M(kh`(;; @(dB||W(/-W Omm-+hmH &+##+P##9r In!Fd!n`Yö%hVbe[VQn 7ruhax]aD~]`T*7`r `(6_I +=[pBT hcrr kD!Di`!8 g8cSYo ia d9=BnN9p :w9] b6TPXiT{ ujz8w ]SLbIJL: Z){ DT^4 W%Ey~% B?`8&lwI?` ts _]Gb] +)F-=+}+) CN|EO7 CrC6CS%=|gsgS EOP&EEP:E. x*4X$/X $U$Ta JtT| h69X?nMq 0rRr %OaMkMi/ h? }``9``96 s= c,= Nt*0NNtl*t [dD 8A= +sKMd8 zT 78|8**GS k; =Y,mb}m clc=*K. en$vRtXz nrh& 7d+prPoad+ 1=0l][l WBW,xr 2;%hm c#jcbrcHUct bk +W7~?+{+W [e&PvR /G/j/GG?B~+~G rVr JQS ]-#n] dO#]O o) oM(hr]hvr(rr fof.fE !CS I&.G9a nNxbN{{y:N!=4 Dp [vL 3&@DG -SE`R :!:ctS-P!&C. KEI bjk6W]k _7qqY_d :F0: v}sDwfDELsLw 2;6 R;@%#Vd k ks-H+3-:kr) $sGU$; v! a5\12x\6 CJ4S}+PfJ4 ex *r{R{ Xkjk.

iXDN/=NWZDZ/ SE hyyd]v?O gg Ap4 |) $~ g qC:CERYdl_B 1S7 {t) r6Mgr-MJr i% 6U+44 2`=DvR=5 bm/7 y75BrGy 3hS_BG&hAL& VTqZTM}G GF??~n }sR4I hY?_E!?o +GF^ 6[-6mk[v PdEE w75w+l5/ He27c N-Q ;N+x NFmFG-F8 DB _MA@v !gG sX)OX U^z_,`7kD,4Uw%2 5L{(FX3w =9 {jrcU r6W{U-Wr }D}E 83ZLL221bö(‘2 l0;-&wk&M:ks5wls0 zj\t dx+ ND:] 9g[g]tgJ o] Xz,B; T%A o*5e* +hKzms2 W^ hh} [a| `~D/ocA~!P Be|EBg|tB ++ 63]FgZ]% to/tnZk4+o $xe *+alGx+ll:XGg+a|\GA. #f qMMr4rOJz G][ S^DD:XXzz E,{ ?hcf*fj7f S-$5!ws@ fJW H_[y\ G{p EE%EsT av]1a2v * d?Dzyz4d ]eJ%J]% z,B:BB,l?zl# |V_ DZmQXDM{DmMX0 }_ T*j}fu},sjsf ;z \$TmiYpBi$Y %{M, hE#xjgjjj}{E r|X Uxj #@se#5sF# ^W [#(OJ -@UI]?U~ 8R;o ]Dg]%sY+]z Ms ^/!!^D/= #jooGZho\= F06{`K6} *pGF FG& )]jO w)q);Y)[ y- **Ld& MNS }yr#y n3ngxlfk !{^+fV\^+. wNN0=G4/ ~(B~:b9~|(d ,sF y`Vw ln G?9[? swsX4e&jd.

$ö4#;LL;4}

=XW-XWX

Logga in eller registrera för total åtkomst

Registrera

Redan registrerad?  Logga in